1st China-UK Symposium on Medicinal Chemistry

Satellite meeting to the 13th Federation of Asian Chemical Societies Congress

15 September 2009
Shanghai, China

A symposium co-organised by the RSC, the CCS (Chinese Chemical Society) and the CPA (the Chinese Pharmaceutical Association) with the aim of bringing together academics and industrialists from both countries and to facilitate research collaborations in the area of medicinal chemistry. 

The meeting will consist of a series of ten key-note lectures from both countries and will also include a poster session sponsored by the RSC, the RSC Organic Division and the British High Commission in Malaysia.

Sponsored by:

Speakers

• Professor Steven Ley, Chemistry Department, Cambridge University, UK 
• Dr David Rees, Astex Therapeutics, UK 
• Dr Ming-Qiang Zhang, F Hoffman-La Roche R & D, China
• Professor Jiandong Jian, Institute of Medicinal Biotechnology, CAMS, China 
• Professor Hualiang Jiang, Shanghai Institute of Materia Medica, CAS, China 
• Professor Dawei Ma, Shanghai Institute of Organic Chemistry, CAS, China 
• Professor Linxiang Zhao, Shenyang Pharmaceutical University, China
• Professor Yang Ye, Shanghai Institute of Materia Medica, CAS, China
• Professor Paul O'Neill, Chemistry Department, Liverpool University, UK
• Dr Anthony Wood, Vice President, Head of Discovery Chemistry, Pfizer, UK 

Organising Committee

• Dr David Alker, David Alker Associates, President of the Industry and Technology Forum, RSC, UK
• Mrs Gwen Jones, Publishing, RSC, UK
• Professor Lihe Zhang, School of Pharmaceutical Sciences, Beijing University, China
• Professor Long Lu, Shanghai Institute of Organic Chemistry and CCS, China
• Dr Alejandra Palermo, Manager, International Projects, RSC, UK
• Dr David Rees, Senior Vice President, Astex Therapeutics, UK
• Dr Ming-Qiang Zhang, Chief Technology Officer, F Hoffman-La Roche R& D, China